MA37872A1 - Sels de composé benzothiazolone utilisés en tant qu'agoniste de beta-2-adrenoceptor - Google Patents
Sels de composé benzothiazolone utilisés en tant qu'agoniste de beta-2-adrenoceptorInfo
- Publication number
- MA37872A1 MA37872A1 MA37872A MA37872A MA37872A1 MA 37872 A1 MA37872 A1 MA 37872A1 MA 37872 A MA37872 A MA 37872A MA 37872 A MA37872 A MA 37872A MA 37872 A1 MA37872 A1 MA 37872A1
- Authority
- MA
- Morocco
- Prior art keywords
- beta
- salts used
- adrenoceptor agonist
- compound salts
- benzothiazolone compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne un composé de formule (i) sous forme de sel acétate (i), un procédé de fabrication du composé de l'invention et ses utilisations thérapeutiques. La présente invention concerne de plus une combinaison de principes pharmacologiquement actifs et des compositions pharmaceutiques.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IQ23912 | 2012-08-30 | ||
| PCT/IB2013/058109 WO2014033654A1 (fr) | 2012-08-30 | 2013-08-29 | Sels de composé benzothiazolone utilisés en tant qu'agoniste de beta-2-adrenoceptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA37872A1 true MA37872A1 (fr) | 2018-07-31 |
Family
ID=53386469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA37872A MA37872A1 (fr) | 2012-08-30 | 2013-08-29 | Sels de composé benzothiazolone utilisés en tant qu'agoniste de beta-2-adrenoceptor |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP3243817A1 (fr) |
| KR (1) | KR20150047586A (fr) |
| CN (2) | CN106146428A (fr) |
| BR (1) | BR112015004127A2 (fr) |
| CA (1) | CA2882877A1 (fr) |
| CL (1) | CL2015000461A1 (fr) |
| CY (1) | CY1120225T1 (fr) |
| DK (1) | DK2890687T3 (fr) |
| EA (1) | EA029946B1 (fr) |
| ES (1) | ES2642003T3 (fr) |
| HK (1) | HK1206015A1 (fr) |
| HR (1) | HRP20171362T1 (fr) |
| HU (1) | HUE033655T2 (fr) |
| IL (1) | IL237382A0 (fr) |
| LT (1) | LT2890687T (fr) |
| MA (1) | MA37872A1 (fr) |
| MX (1) | MX351741B (fr) |
| MY (1) | MY169038A (fr) |
| NZ (1) | NZ705319A (fr) |
| PE (1) | PE20150465A1 (fr) |
| PL (1) | PL2890687T3 (fr) |
| PT (1) | PT2890687T (fr) |
| SA (1) | SA515360076B1 (fr) |
| SG (2) | SG11201501293PA (fr) |
| SI (1) | SI2890687T1 (fr) |
| TN (1) | TN2015000058A1 (fr) |
| WO (1) | WO2014033654A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040962A1 (es) | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
| CA2514733A1 (fr) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Compositions pharmaceutiques a base d'un co-cristal |
| JP2007537187A (ja) | 2004-05-13 | 2007-12-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物 |
| GB0426164D0 (en) * | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| AU2014222362B2 (en) * | 2013-02-28 | 2016-07-21 | Novartis Ag | Formulation comprising benzothiazolone compound |
-
2013
- 2013-08-29 NZ NZ705319A patent/NZ705319A/en not_active IP Right Cessation
- 2013-08-29 PT PT138120753T patent/PT2890687T/pt unknown
- 2013-08-29 LT LTEP13812075.3T patent/LT2890687T/lt unknown
- 2013-08-29 SG SG11201501293PA patent/SG11201501293PA/en unknown
- 2013-08-29 MA MA37872A patent/MA37872A1/fr unknown
- 2013-08-29 ES ES13812075.3T patent/ES2642003T3/es active Active
- 2013-08-29 PL PL13812075T patent/PL2890687T3/pl unknown
- 2013-08-29 MY MYPI2015000453A patent/MY169038A/en unknown
- 2013-08-29 SI SI201330750T patent/SI2890687T1/sl unknown
- 2013-08-29 EP EP17171708.5A patent/EP3243817A1/fr not_active Withdrawn
- 2013-08-29 EP EP13812075.3A patent/EP2890687B1/fr active Active
- 2013-08-29 HU HUE13812075A patent/HUE033655T2/en unknown
- 2013-08-29 DK DK13812075.3T patent/DK2890687T3/en active
- 2013-08-29 PE PE2015000275A patent/PE20150465A1/es not_active Application Discontinuation
- 2013-08-29 WO PCT/IB2013/058109 patent/WO2014033654A1/fr active Application Filing
- 2013-08-29 SG SG10201704377PA patent/SG10201704377PA/en unknown
- 2013-08-29 EA EA201590452A patent/EA029946B1/ru not_active IP Right Cessation
- 2013-08-29 CN CN201610537241.9A patent/CN106146428A/zh active Pending
- 2013-08-29 MX MX2015002656A patent/MX351741B/es active IP Right Grant
- 2013-08-29 KR KR1020157007573A patent/KR20150047586A/ko not_active Application Discontinuation
- 2013-08-29 CA CA2882877A patent/CA2882877A1/fr not_active Abandoned
- 2013-08-29 BR BR112015004127A patent/BR112015004127A2/pt not_active Application Discontinuation
- 2013-08-29 CN CN201380055093.1A patent/CN104736525B/zh not_active Expired - Fee Related
-
2015
- 2015-02-20 TN TNP2015000058A patent/TN2015000058A1/fr unknown
- 2015-02-23 IL IL237382A patent/IL237382A0/en unknown
- 2015-02-25 CL CL2015000461A patent/CL2015000461A1/es unknown
- 2015-02-26 SA SA515360076A patent/SA515360076B1/ar unknown
- 2015-07-08 HK HK15106522.7A patent/HK1206015A1/xx not_active IP Right Cessation
-
2017
- 2017-09-11 HR HRP20171362TT patent/HRP20171362T1/hr unknown
- 2017-09-13 CY CY20171100967T patent/CY1120225T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT2890687T (lt) | 2017-09-11 |
| NZ705319A (en) | 2018-05-25 |
| PT2890687T (pt) | 2017-10-05 |
| BR112015004127A2 (pt) | 2017-07-04 |
| HRP20171362T1 (hr) | 2017-11-03 |
| CN104736525B (zh) | 2016-08-24 |
| SG11201501293PA (en) | 2015-03-30 |
| MX351741B (es) | 2017-10-26 |
| KR20150047586A (ko) | 2015-05-04 |
| SI2890687T1 (sl) | 2017-10-30 |
| CN104736525A (zh) | 2015-06-24 |
| TN2015000058A1 (en) | 2016-06-29 |
| PL2890687T3 (pl) | 2017-11-30 |
| MY169038A (en) | 2019-02-07 |
| EA201590452A1 (ru) | 2015-07-30 |
| MX2015002656A (es) | 2015-05-20 |
| ES2642003T3 (es) | 2017-11-14 |
| EP3243817A1 (fr) | 2017-11-15 |
| HUE033655T2 (en) | 2017-12-28 |
| HK1206015A1 (en) | 2015-12-31 |
| SA515360076B1 (ar) | 2016-03-20 |
| EA029946B1 (ru) | 2018-06-29 |
| IL237382A0 (en) | 2015-04-30 |
| WO2014033654A1 (fr) | 2014-03-06 |
| SG10201704377PA (en) | 2017-06-29 |
| DK2890687T3 (en) | 2017-10-09 |
| CL2015000461A1 (es) | 2015-05-04 |
| EP2890687B1 (fr) | 2017-06-28 |
| CA2882877A1 (fr) | 2014-03-06 |
| EP2890687A1 (fr) | 2015-07-08 |
| PE20150465A1 (es) | 2015-04-22 |
| CY1120225T1 (el) | 2018-12-12 |
| CN106146428A (zh) | 2016-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124882T1 (el) | Αναλογα 1,4-διϋποκατεστημενης πυριδαζινης και μεθοδοι για την θεραπευτικη αγωγη καταστασεων συναφων με ανεπαρκεια smn | |
| MA37405A1 (fr) | Composés hétérocyclyle | |
| MA34837B1 (fr) | Composés indoliques ou analogues de ceux-ci utiles dans le traitement de la dégénérescence maculaire liée à l'âge (dmla) | |
| MA35275B1 (fr) | Composés de tétrahydropyridopyridine et tétrahydropyridopyrimidine et utilisation de ceux-ci en tant que modulateurs de récepteur c5a | |
| EA201592255A1 (ru) | Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания | |
| MA33364B1 (fr) | Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine | |
| EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
| MA35032B1 (fr) | Derives de glycoside et leurs utilisations dans le traitement du diabete | |
| MD20160078A2 (ro) | Inhibitori ai Syk | |
| MA38330A1 (fr) | Dérivés d'acide phosphonique butanoïque de bisphénol substitués en qualité d'inhibiteurs de nep (endopeptidase neutre) | |
| EA201690247A1 (ru) | Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения | |
| EA201492023A1 (ru) | Регуляторы пути комплемента и их применение | |
| PH12015502802A1 (en) | Formulation comprising a hypolipidemic agent | |
| MA39983B1 (fr) | Dérivés de carboxamide | |
| EA201391524A1 (ru) | Производные гликозида и их применение | |
| UA103329C2 (ru) | Соли соединений-ингибиторов вич | |
| MA38679B1 (fr) | Modulateurs du récepteur de cxcr7 | |
| IN2014DN05972A (fr) | ||
| EA201490573A1 (ru) | Соединение бензотиазолона | |
| MA37872A1 (fr) | Sels de composé benzothiazolone utilisés en tant qu'agoniste de beta-2-adrenoceptor | |
| EA201591487A1 (ru) | Производные замещенной бисфенилбутановой кислоты в качестве ингибиторов nep с улучшенной in vivo эффективностью | |
| IN2014MN02433A (fr) | ||
| MA37879B1 (fr) | Forme amorphe stabilisée d'agomélatine, procédé pour sa préparation et compositions pharmaceutiques la contenant | |
| MA34462B1 (fr) | Composes de thiophene 2,3,5- trisubstitues et leurs utilisations | |
| MA38838A1 (fr) | Dérivés de pipéridinyl-indole et leur utilisation en tant qu'inhibiteurs du facteur b du complément |